Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Vidart

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Immunogenetics|January 5, 2011
The HLA-B*83:01 allele is generated by a gene conversion event including whole of exon 2 and partial introns 1 and 2 between B*44 and B*56 allelesI Cervera, M A Herraiz, J A Vidart, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|September 12, 2006
[Detection and typing by molecular biology of human papillomavirus in genital samples]A Suárez Moya, J I Esquivias Gómez, J A Vidart Aragón, et al.
Obstetrics and Gynecology|March 10, 2001
Prognostic value of DNA quantification in early epithelial ovarian carcinomaJ J Valverde, M Martin, J A García-Asenjo, et al.
Gynecologic Oncology|August 25, 2001
A comparison of epithelial membrane antigen overexpression in benign and malignant endometriumP J Coronado, M Fasero, J A Vidart, et al.
The International Journal of Biological Markers|July 10, 1999
Tissue quantification of CA 125 in epithelial ovarian cancerR de la Cuesta, M L Maestro, J Solana, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 23, 2001
P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpressionP J Coronado, J A Vidart, J A Lopez-asenjo, et al.
European Journal of Gynaecological Oncology|May 8, 2007
Brain metastasis and carcinomatous meningitis from vulvar squamous cell carcinoma: case reportJ Puente Vázquez, S López-Tarruella Cobo, F M Antón, et al.
European Journal of Gynaecological Oncology|January 1, 1989
Treatment of advanced ovarian cancer with cisplatin, adriamycin and cyclophosphamide (PAC)E Diaz-Rubio, M Escudero, M Martin-Jimenez, et al.
Breast Cancer Research and Treatment|April 6, 2011
Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancerM Martin, A Romero, M C U Cheang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Immunogenetics|January 5, 2011
The HLA-B*83:01 allele is generated by a gene conversion event including whole of exon 2 and partial introns 1 and 2 between B*44 and B*56 allelesI Cervera, M A Herraiz, J A Vidart, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|September 12, 2006
[Detection and typing by molecular biology of human papillomavirus in genital samples]A Suárez Moya, J I Esquivias Gómez, J A Vidart Aragón, et al.
Obstetrics and Gynecology|March 10, 2001
Prognostic value of DNA quantification in early epithelial ovarian carcinomaJ J Valverde, M Martin, J A García-Asenjo, et al.
Gynecologic Oncology|August 25, 2001
A comparison of epithelial membrane antigen overexpression in benign and malignant endometriumP J Coronado, M Fasero, J A Vidart, et al.
The International Journal of Biological Markers|July 10, 1999
Tissue quantification of CA 125 in epithelial ovarian cancerR de la Cuesta, M L Maestro, J Solana, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 23, 2001
P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpressionP J Coronado, J A Vidart, J A Lopez-asenjo, et al.
European Journal of Gynaecological Oncology|May 8, 2007
Brain metastasis and carcinomatous meningitis from vulvar squamous cell carcinoma: case reportJ Puente Vázquez, S López-Tarruella Cobo, F M Antón, et al.
European Journal of Gynaecological Oncology|January 1, 1989
Treatment of advanced ovarian cancer with cisplatin, adriamycin and cyclophosphamide (PAC)E Diaz-Rubio, M Escudero, M Martin-Jimenez, et al.
Breast Cancer Research and Treatment|April 6, 2011
Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancerM Martin, A Romero, M C U Cheang, et al.
Pageof 1